Elliotts B (QOL Medical, LLC)


Welcome to the PulseAid listing for the Elliotts B drug offered from QOL Medical, LLC. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: QOL Medical, LLC
NON-PROPRIETARY NAME: sodium cation, sodium bicarbonate, anhydrous dextrose, magnesium sulfate, potassium chloride, calcium chloride, sodium phosphate
SUBSTANCE NAME: SODIUM CHLORIDE; SODIUM BICARBONATE; ANHYDROUS DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE; SODIUM PHOSPHATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [Chemical/Ingredient],Cations, Divalent [Chemical/Ingredient]
ROUTE: INTRATHECAL
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2006-09-27
END MARKETING DATE: 0000-00-00


Elliotts B HUMAN PRESCRIPTION DRUG Details:

Item DescriptionElliotts B from QOL Medical, LLC
LABELER NAME: QOL Medical, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 73; 19; 8; 3; 3; 2; 2(mg/10mL; mg/10mL; mg/10mL; mg/10mL; mg/10mL; mg/10mL; mg/10mL)
START MARKETING DATE: 2006-09-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67871-007_6b61a6f9-0cc7-47bf-a600-ae8bb89a9501
PRODUCT NDC: 67871-007
APPLICATION NUMBER: NDA020577

Other SODIUM CHLORIDE; SODIUM BICARBONATE; ANHYDROUS DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE; SODIUM PHOSPHATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Lukare Medical, LLCElliotts B
QOL Medical, LLCElliotts B